Bio-Technology Products

Diagnostic Test Kits For PGI Reagent
1.The status and function of gastric mucosa.
2.Dynamic monitoring of gastric function.

NGAL
1.The optimal marker for early diagnosis of acute kidney injury(AKI).
2.Independent risk index to evaluate the progression of chronic kidney.

PG II
The status and function of gastric mucosa,
Dynamic detection of gastric function,
Early screening of gastric cancer

PCT serum
1.Convenient and accurate solution of bacterial infection.
2.Evaluation indicator of infection degree.
3.Guidance of antibiotics use.

PCT serum
1.Convenient and accurate solution of bacterial infection;
2.Evaluation indicator of infection degree;
3.Guidance of antibiotics use.

The test kit is primarily for the in vitro quantitative determination of
procalcitonin(PCT) content in human whole blood.

Lp-PLA2
1.Registration No: Jiangsu food and drug administration 2014-2400670.
2.Lp is a specific marker for evaluation of plaque stability.

1.The optimal marker for early diagnosis of acute kidney injury(AKI).
2.Independent risk index to evaluate the progression of chronic kidney disease.

The assay is a competitive immunoassay for quantitative determination of FT4 concentration based on chemiluminescence immunoassay technology.

NT-proBNP
1.Routine indicator of heart failure diagnosis and curative effect monitoring
2.Optimal indicator for early detection of heart failure

1.Routine indicator of heart failure diagnosis and curative effect monitoring.
2.Optimal indicator for early detection of heart failure.

NT-proBNP
1.Routine indicator of heart failure diagnosis and curative effect monitoring
2.Optimal indicator for early detection of heart failure

In Vitro Diagnostic Rapid Test Reader
Accruate POCT system
Independent R&D of antigen and antibody
Fast, convenient

Hospital Point of Care Testing Device
Accruate POCT system
Independent R&D of antigen and antibody
Fast, convenient

Negative exclusion indicator of venous thromboembolism
High sensitivity, VTE negative predictive value ≥99%.

The most important indicator of AMI early negative elimination
AMI recurrence detection, most sensitive indicators of reperfusion therapy testing.

Medical Laboratory Equipment Analyzer
Testing speed: 100 samples/ hour
Sample capacity: 36
Reagent capacity: 9
CV≤8%

Medical Laboratory Test Equipment Biochemistry Analyzer
Testing speed: 100 samples/ hour
Sample capacity: 36
Reagent capacity: 9
CV≤8%

H-FABP increase in 30 minutes after Acute Myocardial Infarction(AMI) occurred ,
Early marker of AMI.high specificity for diagnosis of AMI

Gold standard of the AMI diagnosis
1.Ultra sensitive cTnl testing, earlier and more sensitive for AMI diagnosis
2.Recommended to purchase